US-based Nimbus Therapeutics, LLC has signed a definitive agreement under which Japanese pharmaceutical firm Takeda...
Shionogi & Co. has entered into an additional purchasing contract of Xocova (Generic name: ensitrelvir fuma...
Japanese firms Chugai Pharmaceutical and Towa Pharmaceutical have announced that Towa launched Edirol Tablets ...
Olympus Corporation has announced their part in a project in cooperation with the Ministry of Internal Affairs and Commu...
The Global Health Innovative Technology (GHIT) Fund has secured a pledge from global charitable foundation Wellcome...
Japan-based Olympus Corporation has partnered with MedTech Innovator Asia Pacific, the industry's largest healthcare acc...
Kyowa Kirin, a Japan-based global specialty pharmaceutical company, and Germany's Grünenthal GmbH have signed a Joi...
The Global Antibiotic Research and Development Partnership (GARDP) and Japanese firm Sumitomo Pharma Co. have signed an ...
Shimadzu Corporation, Eisai Co., Oita University, and Usuki City Medical Association have announced the commencement of ...
Fujitsu and Wakayama Medical University in Japan have announced the start of joint trials of a technology to support nur...
Hirotsu Bio Science Inc. has announced the commercialisation of "N-NOSE plus Pancreas," the first next-generation "cance...
The Japanese company Chugai Pharmaceutical Co., Ltd., which owns and operates a fully-owned research center "Chugai Phar...
Japan-based Ono Pharmaceutical has entered a worldwide drug discovery collaboration agreement with Poland's Captor The...
Japanese firm Otsuka Pharmaceutical has decided jointly with Takara Bio Inc, to terminate agreements on co-development a...
The Global Health Innovative Technology (GHIT) Fund in Japan has announced a total of approximately 790 million yen...
The Global Innovation Challenge (GIC) Executive Committee, based in Tokyo, has announced that the "Global Inno...
Japan-based Shionogi & Co. has concluded a capital alliance with Lifescapes Inc., a startup arising from Keio U...
Kyowa Kirin, a Japan-based Global Specialty Pharmaceutical company, has announced the appointment of Abdul Mullick...
